Citigroup’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,736
Closed -$24.5K 4960
2024
Q2
$24.5K Sell
10,736
-118,330
-92% -$270K ﹤0.01% 4201
2024
Q1
$558K Buy
129,066
+43,117
+50% +$186K ﹤0.01% 2779
2023
Q4
$262K Buy
85,949
+85,306
+13,267% +$260K ﹤0.01% 3084
2023
Q3
$926 Sell
643
-233
-27% -$336 ﹤0.01% 4348
2023
Q2
$2.18K Sell
876
-779
-47% -$1.94K ﹤0.01% 4538
2023
Q1
$4.44K Sell
1,655
-22,749
-93% -$61K ﹤0.01% 4276
2022
Q4
$133K Sell
24,404
-102,905
-81% -$559K ﹤0.01% 3227
2022
Q3
$1.59M Buy
127,309
+126,097
+10,404% +$1.57M ﹤0.01% 1762
2022
Q2
$6K Sell
1,212
-40,842
-97% -$202K ﹤0.01% 4813
2022
Q1
$320K Sell
42,054
-225,119
-84% -$1.71M ﹤0.01% 3134
2021
Q4
$2.73M Buy
267,173
+129,616
+94% +$1.32M ﹤0.01% 1737
2021
Q3
$1.85M Sell
137,557
-48,244
-26% -$647K ﹤0.01% 1972
2021
Q2
$4.08M Buy
185,801
+9,336
+5% +$205K ﹤0.01% 1577
2021
Q1
$4.25M Buy
176,465
+168,304
+2,062% +$4.05M ﹤0.01% 1434
2020
Q4
$147K Buy
8,161
+4,918
+152% +$88.6K ﹤0.01% 3423
2020
Q3
$37K Sell
3,243
-20,555
-86% -$235K ﹤0.01% 3637
2020
Q2
$577K Sell
23,798
-4,337
-15% -$105K ﹤0.01% 2465
2020
Q1
$310K Buy
28,135
+15,835
+129% +$174K ﹤0.01% 2588
2019
Q4
$325K Sell
12,300
-14,897
-55% -$394K ﹤0.01% 2885
2019
Q3
$620K Buy
27,197
+12,221
+82% +$279K ﹤0.01% 2443
2019
Q2
$459K Buy
14,976
+770
+5% +$23.6K ﹤0.01% 2728
2019
Q1
$236K Sell
14,206
-98,379
-87% -$1.63M ﹤0.01% 3016
2018
Q4
$2.16M Buy
112,585
+77,821
+224% +$1.49M ﹤0.01% 1484
2018
Q3
$1.82M Buy
34,764
+12,463
+56% +$652K ﹤0.01% 1569
2018
Q2
$969K Buy
22,301
+20,318
+1,025% +$883K ﹤0.01% 1903
2018
Q1
$74K Buy
1,983
+120
+6% +$4.48K ﹤0.01% 3547
2017
Q4
$36K Buy
+1,863
New +$36K ﹤0.01% 3973